Crisci Group
Crisci Group is a vertically integrated Australian healthcare and pharmaceutical group operating compounding pharmacy, GMP manufacturing, retail pharmacy (Priceline), medicinal cannabis dispensaries, wellness clinics, and telehealth across 12 locations in four states, serving patients and healthcare practitioners.
- Company typePrivate
- Founded1998
- HeadquartersGlynde, Australia
- Headcount1–10
- GTM typeB2B and B2C
- OfferingServices
What Crisci Group does
Crisci Group is a vertically integrated Australian healthcare and innovative pharmaceutical group, founded in 1998 and headquartered in Glynde, South Australia. The group operates close to 200 staff across 12 locations spanning South Australia, Queensland, Victoria, and New South Wales (most recently Byron Bay, opened February 2026). Its portfolio covers retail pharmacy (Priceline Pharmacy Firle), personalised compounding pharmacy (Cann Compounding, IWG Compounding QLD, Infinity Compounding Pharmacy), TGA-licensed GMP manufacturing (IWG Pharma International), medicinal cannabis dispensaries with integrated on-site clinics (Releaf Dispensaries across VIC, QLD, and NSW), practitioner-led wellness and longevity medicine (Infinity Wellness Group, Integrative Health Solutions), telehealth and clinical services through the Flora Holdings joint venture with ASX-listed Vitura Health, pharmacist-developed skin care and topical formulations, clinical governance and education (ACETC), and internal IT for health and wellness businesses (Genie Tech Solutions).
The underlying technology is an integrated pharmacy, pharmaceutical manufacturing, and wellness platform rather than a discrete software product. Proprietary internal IT infrastructure supports dispensing, compounding, and manufacturing workflows with secure data management, traceability, regulatory reporting, and quality control. Clinical governance and TGA/ARTG compliance frameworks underpin compounding and manufacturing operations. Cann Compounding and Infinity Wellness Group hold LegitScript certification, a credential earned by only a small cohort of healthcare providers globally.
Crisci Group makes money through transaction-fee revenue across six streams: pharmacy dispensing, compounding services, GMP manufacturing (including export-ready supply chains), wellness and longevity consultations, medicinal cannabis dispensary sales, and telehealth/clinic services. Pricing is consultation-based rather than publicly disclosed. Go-to-market combines direct patient-facing pharmacy and dispensary services nationwide, B2B engagement with healthcare practitioners for compounding and emerging-therapy referrals, community-led brand building through charity events and the Little Heroes Foundation partnership, and a sales-led expansion model anchored on the Flora Holdings JV and ongoing clinic acquisitions.
Crisci Group firmographics
Firmographics- Name
- Crisci Group
- Legal name
- Crisci Group
- Website
- https://criscigroup.com
- Company type
- Private
- Founded year
- 1998
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Crisci Group is a vertically integrated Australian healthcare and pharmaceutical group operating compounding pharmacy, GMP manufacturing, retail pharmacy (Priceline), medicinal cannabis dispensaries, wellness clinics, and telehealth across 12 locations in four states, serving patients and healthcare practitioners.
- Ownership category
- akta.pro rank
Crisci Group industry classification
Industry- Product category
- Compounding Pharmacy & Healthcare Services
- NAICS
- Pharmacies and Drug Retailers (456110)
- SIC
- Retail-Drug Stores And Proprietary Stores (5912), Pharmaceutical Preparations (2834)
- akta.pro primary industry
- Cannabis Dispensary + Pharmacy/Clinical Model (Patient Services) (CRANAFAI)
Keywords
Where Crisci Group is headquartered
LocationHeadquarters
- HQ city
- Glynde
- HQ country
- Australia
- HQ region
- Oceania
Offices12 records
Markets served
Crisci Group business model
Business model- GTM type
- B2B and B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure, Supply Chain
Revenue model
- Pharmacy Dispensing: Dispensing of commercially available medicines through Priceline Pharmacy Firle and other retail pharmacy locations
- Compounding Services: Personalised compounding pharmacy services for alternative medicines and tailored formulations through Cann Compounding and Infinity Compounding Pharmacy
- GMP Manufacturing: GMP-certified manufacturing of pharmaceutical-grade products and novel compounds for domestic and international supply chains through IWG Pharma International and Cann Pharma
- Health, Wellness & Longevity: Practitioner-led wellness consultations, health services, and evidence-based formulations through Infinity Wellness Group and Integrative Health Solutions
- Medicinal Cannabis Dispensaries: Releaf Dispensary network providing patient support for alternative medicines dosing and product selection across VIC, QLD, and NSW
- Telehealth & Clinic Services: Face-to-face and telehealth clinical services through Releaf Clinics and Flora Holdings network (including Heyday Medical and Ananda Clinic acquisitions)
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Pay-as-you-go | Consultation-based pricing for pharmacy and healthcare services |
Go-to-market motion3 records
Distribution channels7 records
Marketing channels7 records
Crisci Group product offering
Product offeringCore offering
Crisci Group is a vertically integrated Australian healthcare and pharmaceutical group that operates compounding pharmacies (Cann Compounding, Infinity Compounding Pharmacy, IWG Compounding QLD), a TGA-licensed GMP manufacturing facility (IWG Pharma International), medicinal cannabis dispensaries with on-site clinics (Releaf), a retail pharmacy (Priceline Pharmacy Firle), and practitioner-led wellness and longevity clinics (IWG/Infinity Wellness Group). The group delivers personalised compounded medicines, pharmaceutical-grade novel compounds, medicinal cannabis dispensing, dispensing of commercial medicines, and evidence-based wellness consultations across 12 locations in Australia, supported by an in-house clinical governance framework and customised IT infrastructure.
Product overview
Crisci Group is a vertically integrated Australian healthcare and innovative pharmaceutical group operating a multi-brand portfolio rather than a single unified product. The group encompasses four core service areas: Pharmacy & Compounded Therapies (delivering personalized compounding and medicine dispensing), GMP Manufacturing & Novel Compounds (pharmaceutical-grade production), Health, Wellness & Longevity (practitioner-led consultations), and Skin Care & Topical Formulations (pharmacist-developed skincare). These services are delivered through specialized sub-brands including Cann Health Group (encompassing Cann Compounding and Cann Pharma), Releaf Dispensaries (integrated clinic and pharmacy locations), IWG/Infinity Wellness Group (multidisciplinary wellness), IWG Compounding QLD, IWG Pharma International, Priceline Pharmacy Firle, Australasian Compounders and Emerging Therapies Corporation (ACETC), and Genie Tech Solutions (IT solutions). The group employs close to 200 staff across 12 locations spanning South Australia, Queensland, Victoria, and New South Wales.
Differentiator
Problem solved
Functional benefit
Products and services
- Cann Health Group Parent sub-brand within Crisci Group bringing together Cann Compounding for personalised medicinal cannabis treatment and Cann Pharma for GMP-certified manufacturing of cannabis-based pharmaceutical products, serving patients, practitioners and pharmaceutical partners.
- Cann Compounding Australia's largest compounding pharmacy for alternative medicines, offering personalised treatment and customised dosage forms for individual patients and healthcare practitioners.
- Releaf Dispensaries Dispensary network across Victoria, Queensland and New South Wales providing patient support for alternative medicines dosing and product selection, with integrated on-site clinics for streamlined consultations.
- IWG (Infinity Wellness Group) Multidisciplinary health and wellness group offering an extensive range of wellness products and services, including practitioner-led wellness consultations and evidence-based formulations for preventative health, performance and longevity medicine.
- IWG Compounding QLD Premium 600-square-foot compounding laboratory in Queensland dedicated to expanding delivery of high-quality, customised pharmaceutical solutions to the Queensland market for practitioners and patients.
- IWG Pharma International Australian TGA-licensed facility manufacturing ARTG Listed dosage forms, complementary medicines and food-based supplements for domestic and international pharmaceutical industry partners.
- Priceline Pharmacy Firle Retail pharmacy in Firle, South Australia offering an extensive range of prescription medicines, cosmetics and healthcare products with award-winning customer service and online e-commerce fulfilment.
- Genie Tech Solutions Technology subsidiary providing customised IT solutions to help health and wellness businesses thrive, leveraging internal technology capabilities developed for the Crisci Group network.
Quantifiable outcome
- Over 20,000 patients supported in first year at Cann Compounding Adelaide
- +4 more outcomes
Companies that use Crisci Group
Customer profileNamed customers4 records
Segments5 records
Ideal customer profiles5 records
Crisci Group technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
Crisci Group partnerships and signals
Strategic signalPartnerships
Six partnerships are on record, tiered minor and core.
- HeyDay MedicalminorCann Compounding and HeyDay Medical jointly nominated for Industry Collaboration at the 2025 Cannabiz Awards, reflecting a collaborative partnership in advancing patient care through medicinal cannabis and alternative therapies.
- Vitura Health (ASX: VIT)coreFlora Holdings joint venture between Crisci Group and Vitura Health (50% interest each) to operate Releaf Dispensaries and Clinics network. The joint venture acquired Releaf Group Limited assets and is expanding the dispensary network nationally. The JV combines Crisci Group's dispensary operations with Vitura Health's resources to transform the alternative healthcare landscape in Australia.
- ANTG (Ananda Clinic)coreFlora Holdings acquired Ananda Clinic from ANTG as part of the expansion of the Releaf Clinic and Dispensary network. The acquisition strengthens patient access to integrative and emerging therapies across Australia through both brick-and-mortar clinics and growing telehealth services.
- Heyday Medical CliniccoreFlora Holdings (joint venture between Crisci Group and Vitura Health) acquired key assets of Heyday Medical Clinic, one of Australia's most respected alternative therapy clinics. Heyday Medical has delivered high-quality holistic care to over 5,000 patients since 2020. The acquisition significantly strengthens Flora's clinical network and positions the JV as a national leader in face-to-face and telehealth services.
- Little Heroes FoundationminorCrisci Group is a proud supporter of the Little Heroes Foundation, which improves the lives of seriously ill children and their families by funding medical equipment, family support programs and hospital infrastructure. Crisci Group has fundraised through City to Bay Fun Run, June Push up Challenge, movie nights, and sponsorships including the 2025 Melbourne Cup Luncheon. $1 from all Bio-Magnesium sales between July-September 2024 and 2025 were donated to the foundation.
- Priceline PharmacycoreCrisci Group operates Priceline Pharmacy Firle as a franchisee under the Priceline brand. The store offers an extensive range of prescription medicines, cosmetics, and healthcare products, benefiting from the national Priceline brand recognition, awards, and customer referral network.
Scale indicators10 records
Recent moves12 records
Expansion highlights6 records
Crisci Group competitors and assessment
Company assessmentEmerging players
- ECS Botanics: ASX-listed Australian medicinal cannabis and hemp producer with manufacturing and white-label capabilities. Comparable at the manufacturing and product-formulation layer to Cann Pharma and IWG Compounding, though at smaller scale.
- Bod Australia (now Health House International): ASX-listed medicinal cannabis and wellness products company focused on Australian and European distribution. Comparable in medicinal cannabis product development, practitioner channels, and wellness positioning.
Broad incumbents
- Chemist Warehouse: Largest Australian retail pharmacy chain. Overlaps with Priceline Pharmacy Firle on prescription dispensing and OTC/health retail, but operates at vastly larger national scale — a key competitive reference for Crisci's retail pharmacy leg.
- MediPharm Labs: Canada-listed GMP contract manufacturer of cannabis-based pharmaceutical products. Overlaps with IWG Pharma International on GMP contract manufacturing capabilities and export-ready pharmaceutical-grade cannabis production.
Direct peers
- Little Green Pharma: ASX-listed medicinal cannabis producer with TGA-GMP manufacturing and Australian/European distribution. Comparable in GMP manufacturing capabilities, cannabis-based formulations, and practitioner-channel go-to-market.
- Vitura Health (formerly Cronos Australia): ASX-listed alternative healthcare and medicinal cannabis company; operates the Flora Holdings JV with Crisci Group at 50/50, owning Releaf Dispensaries and Clinics. Directly comparable in patient channels, medicinal cannabis SKUs, and clinic/dispensary hybrid model.
- Althea Group Holdings: ASX-listed medicinal cannabis company with patient-facing channels in Australia and the UK. Comparable in medicinal cannabis dispensing, practitioner education, and clinic-style patient access models.
- ANTG (Australian Natural Therapeutics Group): Australian medicinal cannabis cultivator and product supplier whose Ananda Clinic was acquired by Flora Holdings (Crisci's JV). Overlaps in medicinal cannabis products, prescriber channels, and clinical patient access.
- Cannim Group: Australian medicinal cannabis producer and GMP manufacturer with global distribution. Comparable in GMP manufacturing, cannabinoid formulation, and practitioner channels; former employer of Crisci's CSO Dr. Kylie O'Brien.
Others
- Priceline Pharmacy (API / Souls Group): Australian retail pharmacy brand franchisor under which Crisci operates Priceline Pharmacy Firle. Indirect peer as the parent brand relationship influences Crisci's retail pharmacy traffic, pricing, and supplier access.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks6 records
Key highlights6 records
Customer concentration
Crisci Group social profiles
Digital presenceCrisci Group financial estimates
Financial estimateRevenue estimate
Valuation estimate
Crisci Group leadership team
Management profileNumber of profiles
Profiles6 records
Crisci Group subsidiaries and ownership
Company hierarchySubsidiaries10 records
Crisci Group funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Crisci Group M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Crisci Group
What does Crisci Group do?
Crisci Group is a vertically integrated Australian healthcare and pharmaceutical group that operates compounding pharmacies (Cann Compounding, Infinity Compounding Pharmacy, IWG Compounding QLD), a TGA-licensed GMP manufacturing facility (IWG Pharma International), medicinal cannabis dispensaries with on-site clinics (Releaf), a retail pharmacy (Priceline Pharmacy Firle), and practitioner-led wellness and longevity clinics (IWG/Infinity Wellness Group). The group delivers personalised compounded medicines, pharmaceutical-grade novel compounds, medicinal cannabis dispensing, dispensing of commercial medicines, and evidence-based wellness consultations across 12 locations in Australia, supported by an in-house clinical governance framework and customised IT infrastructure.
Is Crisci Group a public or private company?
Crisci Group is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Crisci Group founded?
Crisci Group was founded in 1998. It employs 1 to 10 people.
Where is Crisci Group based?
Crisci Group is headquartered in Glynde, Australia, in the Oceania region.
How does Crisci Group make money?
Six revenue lines are on record. Pharmacy Dispensing is the primary driver. The others are compounding Services, GMP Manufacturing, health, Wellness & Longevity, medicinal Cannabis Dispensaries and telehealth & Clinic Services.
Who are Crisci Group's main competitors?
Emerging players on record are ECS Botanics and Bod Australia (now Health House International). Broad incumbents are Chemist Warehouse and MediPharm Labs. Direct peers are Little Green Pharma, Vitura Health (formerly Cronos Australia), Althea Group Holdings, ANTG (Australian Natural Therapeutics Group) and Cannim Group. Priceline Pharmacy (API / Souls Group) is listed as an others.
Does Crisci Group have an API?
No public API is recorded for Crisci Group.
What industry is Crisci Group in?
Crisci Group's product category is Compounding Pharmacy & Healthcare Services. Its primary akta.pro industry code is CRANAFAI, Cannabis Dispensary + Pharmacy/Clinical Model (Patient Services). Its NAICS code is 456110 and its SIC code is 5912.